Pyrimidine derivatives for the prevention of HIV infection

Details for Australian Patent Application No. 2004210081 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Pasquier, Elisabeth Therese Jeanne; Guillemont, Jerome Emile Georges; Lewi, Paulus Joannes; Janssen, Paul Adriaan Jan; Koymans, Lucien Maria Henricus; Daeyaert, Frederik Frans Desire; Heeres, Jan; De Jonge, Marc Rene; Vinkers, Hendrik Maarten

Agent Shelston IP

Pub. Number AU-B-2004210081

PCT Pub. Number WO2004/069812

Priority PCT/EP03/01291 07.02.03 EP

Filing date 4 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 26 November 2009

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/069812 Priority application(s): WO2004/069812

3 November 2005 Amendment Made

  The nature of the amendment is: Add the co-inventor Guillemont, Jerome Emile Georges and Pasquier, Elisabeth Therese Jeanne

26 November 2009 Application Accepted

  Published as AU-B-2004210081

25 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210082-2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them

2004210071-Mercaptoimidazoles as CCR2 receptor antagonists